Are you Dr. Huang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-880-7812
Summary
- Dr. Susan (Hsi) Huang, MD is an infectious disease specialist in Orange, California. She is currently licensed to practice medicine in California and Massachusetts. She is affiliated with UCI Health and is a Lecturer on Medicine at Channing Laboratory.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2000 - 2004
University of California (San Francisco)Residency, Internal Medicine, 1997 - 2000
Johns Hopkins University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2007 - 2025
MA State Medical License 1999 - 2012- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs) Start of enrollment: 2009 Sep 01
- Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance Start of enrollment: 2011 Jan 01
- Active Bathing to Eliminate Infection (ABATE Infection) Trial Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 45 citationsA guide to research partnerships for pragmatic clinical trialsKarin E. Johnson, Chris Tachibana, Gloria D. Coronado, Laura M. Dember, Russell E. Glasgow
BMJ. 2014-12-01 - 9 citationsTrials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.Eric B. Larson, Chris Tachibana, Ella Thompson, Gloria D. Coronado, Lynn DeBar
Healthcare. 2016-09-01 - 180 citationsRapid detection of single bacteria in unprocessed blood using Integrated Comprehensive Droplet Digital DetectionDong-Ku Kang, M. Monsur Ali, Kaixiang Zhang, Susan S. Huang, Ellena M. Peterson
Nature Communications. 2014-11-13
Press Mentions
Destiny Pharma PLC (DEST.L) Study Gives Strong Support for Potential of XF-73 & CEO InterviewOctober 18th, 2021- Destiny Pharma : Study Gives Strong Support for Potential of XF-73October 18th, 2021
- Coronavirus Briefing: What Happened TodayApril 29th, 2021
- Join now to see all
Grant Support
- Epicenters III: Translational Research To Prevent Healthcare Associated InfectionCenters For Disease Control And Prevention2011–2012
- Public Health Prevention Fund (PPHF) Ventilator Associated Pneumonia ACACenters For Disease Control And Prevention2011
- Project Clear - Changing Lives By Eradicating Antibiotic ResistanceAgency For Healthcare Research And Quality2010–2011
- Modeling Health System Infectious Disease DataNational Institute Of General Medical Sciences2010
- Comparative Effectiveness Of MRSA Decolonization StrategiesNational Institute Of Allergy And Infectious Diseases2010
- Improving Assessment Of MRSA &Vre Transmission In IcusNational Institute Of Allergy And Infectious Diseases2007–2009
- Improving Assessment Of MRSA &Vre Transmission In IcusNational Institute Of Allergy And Infectious Diseases2005–2006
- Modeling Antimicrobial Resistance In CommunitiesNational Institute Of Allergy And Infectious Diseases2001–2002
